IRCT20120215009014N214尚未招募2 期
Effect of Nano-curcumin versus not receiving it on serum levels of Betatrophin and Irisin in patients with metabolic syndrome: a before-after clinical trial
适应症
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 70 years（—）
- 性别
- All
入选标准
- •Age: 18 to 70 years old
- •Metabolic syndrome diagnosis
排除标准
- •Thyroid disease
- •Liver disease
- •Renal disease
- •Using interfering drugs with carbohydrate and lipid metabolism
研究者
相似试验
招募中
3 期
?Studing the effect of Nano-curcumin and curcumoup in primary dysmenorrheaIRCT20160813029327N11Islamic Azad University180
已完成
3 期
The effects of nano-curcumin on obstructive pulmonary disease patientsIRCT20191222045853N1Oroumia University of Medical Sciences60
尚未招募
3 期
Investigating the effect of nanocurcumin in psychotic methamphetamine usersPsychotic methamphetamine users.???????? ????? ? ?????? ???? ?? ???? ???? ?????????F10-F19IRCT20240208060938N1Kashan University of Medical Sciences50
已完成
2 期
Therapeutic Effects of Curcumin as Supplement on Metabolic SyndromeCondition 1: Hypertension. Condition 2: Hyperglyceridaemia. Condition 3: Prediabetic. Condition 4: low HDL-C.Secondary hypertension, unspecifiedPure hyperglyceridaemiaAbnormal glucose tolerance testHigh-density lipoprotein deficiencyIRCT2016021326530N1Vice – Chancellery of Research & Technology Affairs of Kermanshah University of Medical Sciences90
招募中
3 期
The effect of Nanocurcumin on liver fibrosisiver fibrosis.IRCT20210427051098N2Yazd University of Medical Sciences50